Smith & Nephew (LON:SN) Earns Outperform Rating from Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Smith & Nephew (LON:SN) in a research note issued to investors on Tuesday, Marketbeat Ratings reports. Royal Bank of Canada currently has a GBX 1,500 ($18.84) target price on the stock.

Other equities research analysts also recently issued reports about the company. Barclays reaffirmed an equal weight rating and set a GBX 1,150 ($14.45) target price on shares of Smith & Nephew in a report on Friday, February 9th. Berenberg Bank reiterated a buy rating and issued a GBX 1,450 ($18.22) target price on shares of Smith & Nephew in a report on Thursday, May 2nd. Jefferies Financial Group reiterated a buy rating and issued a GBX 1,250 ($15.70) target price on shares of Smith & Nephew in a research report on Friday, May 3rd. Finally, JPMorgan Chase & Co. boosted their price target on shares of Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the company an overweight rating in a report on Thursday, May 2nd. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average price target of GBX 1,346.20 ($16.91).

Smith & Nephew Stock Performance

SN stock opened at GBX 1,001.50 ($12.58) on Tuesday. The company has a 50-day simple moving average of GBX 1,009.89 and a 200 day simple moving average of GBX 1,036.23. The company has a market capitalization of £8.76 billion, a P/E ratio of 4,172.92, a PEG ratio of 0.46 and a beta of 0.51. The company has a quick ratio of 0.84, a current ratio of 1.77 and a debt-to-equity ratio of 59.11. Smith & Nephew has a fifty-two week low of GBX 887 ($11.14) and a fifty-two week high of GBX 1,316.75 ($16.54).

Smith & Nephew Increases Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Thursday, March 28th will be issued a dividend of $0.23 per share. This represents a yield of 1.62%. This is an increase from Smith & Nephew’s previous dividend of $0.14. The ex-dividend date of this dividend is Thursday, March 28th. Smith & Nephew’s payout ratio is presently 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.